Similarly, a high proportion of MITF+ cells at baseline (Supplementary Figure S6B, available at https://doi.org/10.1016/j.iotech.2024.101009), irrespective of AXL status, as well as of any of the four AXL/MITF melanoma cell subpopulations (Supplementary Figure S6C, available at https://doi.org/10.1016/j.iotech.2024.101009), did not significantly affect the survival probability. This evidence concerns the gene MITF and melanoma.